Please login to the form below

Not currently logged in
Email:
Password:

Merck gets US green light for allergy immunotherapy

FDA headquarters White OakExpected to provide a significant boost to company's partner Alk-Abello

BMS files fixed-dose HIV combination in US

Bristol-Myers Squibb (BMS) buildingCombines Reyataz with Gilead Sciences' cobicistat

HRW to expand into the US

Caroline_JamesonWill open east coast office in May

Oral hepatitis C regimens tackle advanced liver disease

Merck and Co - US headquarters New data released at the International Liver Congress by AbbVie, Merck & Co and Gilead

GSK under investigation in Poland for 'camouflaged bribes'

GSK - logo on buildingA regional manager and 11 doctors have been charged, according to a BBC report

Pharma shares data on cancer projects

Project Data Sphere logoProject Data Sphere involves AZ, Bayer, Celgene, Janssen, Pfizer and Sanofi

Herceptin could face biosimilars in UK later this year

Roche Herceptin trastuzumab cancerCourt overturns patents protecting Roche’s cancer drug

Lilly to use real-world data in diabetes collaboration

Eli Lilly HQ thumbPartners with T1D Exchange to research ways to provide type 1 diabetes care

This month in 1917: A tale of two Mercks

US enters World War I severing ties between Merck & Co and its German parent

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Clarity of vision, insight and a thought-through strategic approach are our tools for delivering solutions that benefit our clients and...

Latest intelligence

England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....
Pharma deal watch - handshake
Pharma deals during March 2014
Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month...